by Sandrine Miller | Mar 26, 2021 | News
Separating microbes and cancers The role of microorganisms in causing and sustaining cancers has been in dispute for centuries. Through the lens of gut- and tumor-associated microbes, Sepich-Poore et al. review our current understanding of the microbiota in cancer,...
by Sandrine Miller | Feb 22, 2021 | News
Micronoma, a San Diego, Calif.-based cancer detection biotech company that utilizes signals from the tumor-related microbiome to diagnose cancer at an early stage with liquid biopsy technology, closed a $3.5m convertible debt financing round. Read full...
by Sandrine Miller | Dec 14, 2020 | News
Read the article at CIO...
by Sandrine Miller | Nov 5, 2020 | News
SAN DIEGO, Calif., Nov. 5, 2020 /PRNewswire/ — Micronoma, an early-stage cancer detection biotech company seeking to develop and commercialize a minimally-invasive, unique microbiome-based assay, today announced their company expansion with three key executive...
by Sandrine Miller | Oct 7, 2020 | News
San Diego-based Micronoma, a startup using microbiome analysis for early cancer detection, has appointed Magda Marquet as chairman of the firm’s board. “I am excited to see our team growing so strong,” said Sandrine Miller-Montgomery, CEO of...
